Download PDF
Planta Med 2017; 83(05): 398-404
DOI: 10.1055/s-0042-105293
Formulation and Delivery Systems of Natural Products
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Nanostructured Lipid Carriers (NLC) as Vehicles for Topical Administration of Sesamol: In Vitro Percutaneous Absorption Study and Evaluation of Antioxidant Activity

Carmelo Puglia
1   Department of Drug Sciences, University of Catania, Catania, Italy
,
Maria Rosaria Lauro
2   Department of Pharmacy, University of Salerno, Fisciano (SA), Italy
,
Alessia Offerta
1   Department of Drug Sciences, University of Catania, Catania, Italy
,
Lucia Crascì
1   Department of Drug Sciences, University of Catania, Catania, Italy
,
Lucia Micicchè
1   Department of Drug Sciences, University of Catania, Catania, Italy
,
Anna Maria Panico
1   Department of Drug Sciences, University of Catania, Catania, Italy
,
Francesco Bonina
1   Department of Drug Sciences, University of Catania, Catania, Italy
,
Giovanni Puglisi
1   Department of Drug Sciences, University of Catania, Catania, Italy
› Author Affiliations
Further Information

Publication History

received 29 October 2015
revised 01 February 2016

accepted 10 March 2016

Publication Date:
28 April 2016 (online)

Also available at
   Permissions and Reprints

Abstract

Sesamol is a natural phenolic compound extracted from Sesamum indicum seed oil. Sesamol is endowed with several beneficial effects, but its use as a topical agent is strongly compromised by unfavorable chemical-physical properties. Therefore, to improve its characteristics, the aim of the present work was the formulation of nanostructured lipid carriers as drug delivery systems for topical administration of sesamol.

Two different nanostructured lipid carrier systems have been produced based on the same solid lipid (Compritol® 888 ATO) but in a mixture with two different kinds of oil phase such as Miglyol® 812 (nanostructured lipid carrier-M) and sesame oil (nanostructured lipid carrier-PLUS). Morphology and dimensional distribution of nanostructured lipid carriers have been characterized by differential scanning calorimetry and photon correlation spectroscopy, respectively. The release pattern of sesamol from nanostructured lipid carriers was evaluated in vitro determining drug percutaneous absorption through excised human skin. Furthermore, an oxygen radical absorbance capacity assay was used to determine their antioxidant activity.

From the results obtained, the method used to formulate nanostructured lipid carriers led to a homogeneous dispersion of particles in a nanometric range. Sesamol has been encapsulated efficiently in both nanostructured lipid carriers, with higher encapsulation efficiency values (> 90 %) when sesame oil was used as the oil phase (nanostructured lipid carrier-PLUS).

In vitro evidences show that nanostructured lipid carrier dispersions were able to control the rate of sesamol diffusion through the skin, with respect to the reference formulations.

Furthermore, the oxygen radical absorbance capacity assay pointed out an interesting and prolonged antioxidant activity of sesamol, especially when vehiculated by nanostructured lipid carrier-PLUS.

Key words

Sesamum indicum - Pedaliaceae - NLC - in vitro percutaneous absorption - Franz cells - DSC - ORAC assay
 

  • References

  • 1 Kaur IP, Saini A. Sesamol exhibits antimutagenic activity against oxygen species mediated mutagenicity. Mutat Res 2000; 470: 71-76
    CrossrefPubMedGoogle Scholar
  • 2 Kapadia GJ, Azuine MA, Tokuda H, Takasaki M, Mukainaka T, Konoshima T, Nishino H. Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis. Pharmacol Res 2002; 45: 499-505
    CrossrefPubMedGoogle Scholar
  • 3 Shimizu S, Fujii G, Takahashi M, Nakanishi R, Komiya M, Shimura M, Noma N, Onuma W, Terasaki M, Yano T, Mutoh M. Sesamol suppresses cyclooxygenase-2 transcriptional activity in colon cancer cells and modifies intestinal polyp development in Apc (Min/+) mice. J Clin Biochem Nutr 2014; 54: 95-101
    CrossrefPubMedGoogle Scholar
  • 4 Sharma S, Kaur IP. Development and evaluation of sesamol as an antiaging agent. Int J Dermatol 2006; 45: 200-208
    CrossrefPubMedGoogle Scholar
  • 5 Baek S. Sesamol decreases melanin biosynthesis in melanocyte cells and zebrafish: Possible involvement of MITF via the intracellular cAMP and p 38/JNK signaling pathways. Exp Dermatol 2015; 24: 761-766
    CrossrefPubMedGoogle Scholar
  • 6 Srisayam M, Weerapreeyakul N, Barusrux S, Kanokmedhakul K. Antioxidant, antimelanogenic, and skin-protective effect of sesamol. J Cosmet Sci 2014; 65: 69-79
    PubMedGoogle Scholar
  • 7 Müller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 2002; 242: 121-128
    CrossrefPubMedGoogle Scholar
  • 8 Puglia C, Bonina F. Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals. Expert Opin Drug Deliv 2012; 9: 429-441
    CrossrefPubMedGoogle Scholar
  • 9 Puglia C, Damiani E, Offerta A, Rizza L, Tirendi GG, Tarico MS, Curreri S, Bonina F, Perrotta RE. Evaluation of nanostructured lipid carriers (NLC) and nanoemulsions as carriers for UV-filters: characterization, in vitro penetration and photostability studies. Eur J Pharm Sci 2014; 51: 211-217
    CrossrefPubMedGoogle Scholar
  • 10 Puglia C, Sarpietro MG, Bonina F, Castelli F, Zammataro M, Chiechio S. Development, characterization, and in vitro and in vivo evaluation of benzocaine- and lidocaine-loaded nanostructrured lipid carriers. J Pharm Sci 2011; 100: 1892-1899
    CrossrefPubMedGoogle Scholar
  • 11 Pinto MF, Moura CC, Nunes C, Segundo MA, Costa Lima SA, Reis S. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers. Int J Pharm 2014; 477: 519-526
    CrossrefPubMedGoogle Scholar
  • 12 Ricci M, Puglia C, Bonina F, Di Giovanni C, Giovagnoli S, Rossi C. Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies. J Pharm Sci 2005; 94: 1149-1159
    CrossrefPubMedGoogle Scholar
  • 13 Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatologicalpreparations. Adv Drug Deliv Rev 2002; 54: S131-S155
    CrossrefPubMedGoogle Scholar
  • 14 Wan Y, Li H, Fu G, Chen X, Chen F, Xie M. The relationship of antioxidant components and antioxidant activity of sesame seed oil. J Sci Food Agric 2015; 95: 2571-2578
    CrossrefPubMedGoogle Scholar
  • 15 Yoshida H, Shigezaki J, Takagi S, Kajimoto G. Variation in the composition of various acyl lipid, tocopherols and lignans in sesame seed oil roasted in a microwave oven. J Sci Food Agric 1995; 68: 407-415
    CrossrefPubMedGoogle Scholar
  • 16 Namiki M, Fukuda Y, Takei Y, Namiki K, Koizumi Y. Changes in functional factors of sesame seed and oil during various types of processing. ACS Symp Ser 2002; 816: 85-104
    PubMedGoogle Scholar
  • 17 Yoshida H, Takagi S. Antioxidative effects of sesamol and tocopherols at various concentrations in oils during microwave heating. J Sci Food Agric 1999; 79: 220-226
    CrossrefPubMedGoogle Scholar
  • 18 Puglia C, Offerta A, Rizza L, Zingale G, Bonina F, Ronsisvalle S. Optimization of curcumin loaded lipid nanoparticles formulated using high shear homogenization (HSH) and ultrasonication (US) methods. J Nanosci Nanotechnol 2013; 13: 6888-6893
    CrossrefPubMedGoogle Scholar
  • 19 Mitri K, Shegokar R, Gohla S, Anselmi C, Müller RH. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance. Int J Pharm 2011; 414: 267-275
    CrossrefPubMedGoogle Scholar
  • 20 Catenacci L, Sorrenti M, Bruni G, Bonferoni MC, Sandri G, Bettinetti G. Characterization of silver sulfadiazine-loaded solid lipid nanoparticles by thermal analysis. J Therm Anal Calorim 2013; 111: 2149-2215
    CrossrefPubMedGoogle Scholar
  • 21 Dan S, Ng WK, Tan RBH. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?. Eur J Pharm Sci 2012; 47: 139-151
    CrossrefPubMedGoogle Scholar
  • 22 Lombardi Borgia S, Regehly M, Sivaramakrishnan R, Mehnert W, Korting HC, Danker K, Röder B, Kramer KD, Schäfer-Korting M. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J Control Release 2005; 110: 151-163
    CrossrefPubMedGoogle Scholar
  • 23 Chen H, Chang X, Du D, Liu W, Liu J, Weng T, Yang Y, Xu H, Yang X. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release 2006; 110: 296-306
    CrossrefPubMedGoogle Scholar
  • 24 Geetha T, Kapila M, Prakash O, Deol PK, Kakkar V, Kaur IP. Sesamol-loaded solid lipid nanoparticles for treatment of skin cancer. J Drug Target 2015; 23: 159-169
    CrossrefPubMedGoogle Scholar
  • 25 Silvestre MP, Chaiyasit W, Brannan RG, McClements DJ, Decker EA. Ability of surfactant head group size to alter lipid and antioxidant oxidation in oil-in-water emulsions. J Agric Food Chem 2000; 48: 2057-2061
    CrossrefPubMedGoogle Scholar
  • 26 Carvalho RHR, Galvao EL, Barros JAC, Conceicao MM, Sousa EMBD. Extraction, fatty acid profile and antioxidant activity of sesame extract (Sesamum Indicum L.). Braz J Chem Eng 2012; 29: 409-420
    CrossrefPubMedGoogle Scholar
  • 27 Bopitiya D, Madhujith T. Antioxidant activity and total phenolic content of sesame (Sesamum indicum L.) seed oil. Trop Agric Res 2013; 24: 296-302
    PubMedGoogle Scholar
  • 28 Kligman AM, Christophers E. Preparation of isolated sheets of human stratum corneum. Arch Dermatol 1963; 88: 702-705
    CrossrefPubMedGoogle Scholar
  • 29 Swarbrick J, Lee G, Brom J. Drug permeation through human skin. I. Effects of storage conditions of skin. J Invest Dermatol 1982; 78: 63-66
    CrossrefPubMedGoogle Scholar
  • 30 Bronaugh RL, Stewart RF, Simon M. Methods for in vitro percutaneous absorption studies. VII: Use of excised human skin. J Pharm Sci 1986; 75: 1094-1097
    CrossrefPubMedGoogle Scholar
  • 31 Toitou E, Fabin B. Altered skin permeation of highly lipophilic molecule: Tetrahydrocannabinol. Int J Pharm 1988; 43: 17-22
    CrossrefPubMedGoogle Scholar
  • 32 Merrell JG, McLaughlin SW, Tie L, Laurencin CT, Chen AF, Nair LS. Curcumin-loaded poly(epsilon-caprolactone) nanofibres: diabetic wound dressing with anti-oxidant and anti-inflammatory properties. Clin Exp Pharmacol Physiol 2009; 36: 1149-1156
    CrossrefPubMedGoogle Scholar